Association predictions of genomics, proteinomics, transcriptomics, microbiome, metabolomics, pathomics, radiomics, drug, symptoms, environment factor, and disease networks: A comprehensive approach
- PMID: 34346083
- DOI: 10.1002/med.21847
Association predictions of genomics, proteinomics, transcriptomics, microbiome, metabolomics, pathomics, radiomics, drug, symptoms, environment factor, and disease networks: A comprehensive approach
Abstract
Currently, the research of multi-omics, such as genomics, proteinomics, transcriptomics, microbiome, metabolomics, pathomics, and radiomics, are hot spots. The relationship between multi-omics data, drugs, and diseases has received extensive attention from researchers. At the same time, multi-omics can effectively predict the diagnosis, prognosis, and treatment of diseases. In essence, these research entities, such as genes, RNAs, proteins, microbes, metabolites, pathways as well as pathological and medical imaging data, can all be represented by the network at different levels. And some computer and biology scholars have tried to use computational methods to explore the potential relationships between biological entities. We summary a comprehensive research strategy, that is to build a multi-omics heterogeneous network, covering multimodal data, and use the current popular computational methods to make predictions. In this study, we first introduce the calculation method of the similarity of biological entities at the data level, second discuss multimodal data fusion and methods of feature extraction. Finally, the challenges and opportunities at this stage are summarized. Some scholars have used such a framework to calculate and predict. We also summarize them and discuss the challenges. We hope that our review could help scholars who are interested in the field of bioinformatics, biomedical image, and computer research.
Keywords: association predictions; biological network construction; deep learning; feature extraction; multi-omics data fusion.
© 2021 Wiley Periodicals LLC.
Similar articles
-
Illuminating the oral microbiome and its host interactions: recent advancements in omics and bioinformatics technologies in the context of oral microbiome research.FEMS Microbiol Rev. 2023 Sep 5;47(5):fuad051. doi: 10.1093/femsre/fuad051. FEMS Microbiol Rev. 2023. PMID: 37667515 Free PMC article. Review.
-
A Detailed Catalogue of Multi-Omics Methodologies for Identification of Putative Biomarkers and Causal Molecular Networks in Translational Cancer Research.Int J Mol Sci. 2021 Mar 10;22(6):2822. doi: 10.3390/ijms22062822. Int J Mol Sci. 2021. PMID: 33802234 Free PMC article. Review.
-
Integrating pathomics with radiomics and genomics for cancer prognosis: A brief review.Chin J Cancer Res. 2021 Oct 31;33(5):563-573. doi: 10.21147/j.issn.1000-9604.2021.05.03. Chin J Cancer Res. 2021. PMID: 34815630 Free PMC article.
-
[A multi-omics approach to investigate the etiology of non-communicable diseases: recent advance and applications].Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Jan 10;42(1):1-9. doi: 10.3760/cma.j.cn112338-20201201-01370. Zhonghua Liu Xing Bing Xue Za Zhi. 2021. PMID: 33503692 Chinese.
-
Unfolding and de-confounding: biologically meaningful causal inference from longitudinal multi-omic networks using METALICA.mSystems. 2024 Oct 22;9(10):e0130323. doi: 10.1128/msystems.01303-23. Epub 2024 Sep 6. mSystems. 2024. PMID: 39240096 Free PMC article.
Cited by
-
A Novel Phenazine Analog, CPUL1, Suppresses Autophagic Flux and Proliferation in Hepatocellular Carcinoma: Insight from Integrated Transcriptomic and Metabolomic Analysis.Cancers (Basel). 2023 Mar 5;15(5):1607. doi: 10.3390/cancers15051607. Cancers (Basel). 2023. PMID: 36900398 Free PMC article.
-
Deciphering the role of ELAVL1: Insights from pan-cancer multiomics analyses with emphasis on nasopharyngeal carcinoma.J Transl Int Med. 2025 May 8;13(2):138-155. doi: 10.1515/jtim-2025-0009. eCollection 2025 Apr. J Transl Int Med. 2025. PMID: 40443402 Free PMC article.
-
Prediction of Early Visual Outcome of Small-Incision Lenticule Extraction (SMILE) Based on Deep Learning.Ophthalmol Ther. 2023 Apr;12(2):1263-1279. doi: 10.1007/s40123-023-00680-6. Epub 2023 Feb 24. Ophthalmol Ther. 2023. PMID: 36826752 Free PMC article.
-
Deep Learning With Radiomics for Disease Diagnosis and Treatment: Challenges and Potential.Front Oncol. 2022 Feb 17;12:773840. doi: 10.3389/fonc.2022.773840. eCollection 2022. Front Oncol. 2022. PMID: 35251962 Free PMC article. Review.
-
Polygenic Risk Score for Cardiovascular Diseases in Artificial Intelligence Paradigm: A Review.J Korean Med Sci. 2023 Nov 27;38(46):e395. doi: 10.3346/jkms.2023.38.e395. J Korean Med Sci. 2023. PMID: 38013648 Free PMC article. Review.
References
REFERENCES
-
- Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet. 2003;33(suppl):228-237.
-
- Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857-866.
-
- Wang W, Lou W, Ding B, et al. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer. Aging. 2019;11(9):2610-2627.
-
- Soudyab M, Iranpour M, Ghafouri-Fard S. The role of long non-coding RNAs in breast cancer. Arch Iran Med. 2016;19(7):508-517.
-
- Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):94.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical